首页|期刊导航|中国食品药品监管|储配商评级管理在疫苗流通质量提升中的应用和评价

储配商评级管理在疫苗流通质量提升中的应用和评价OA

Application and Evaluation of Storage and Distribution Provider Rating Management in Enhancing Vaccine Distribution Quality

中文摘要英文摘要

为提高非免疫规划疫苗的全国配送效率并降低配送成本,疫苗生产企业在遵循疫苗流通相关法规要求的基础上,采用"干线运输+区域仓储+区域配送"的分段接力方式,推动了疫苗流通领域的发展.同时,相关企业建立了储配商评级管理制度,以促进疫苗流通质量提升.本文系统阐述了评级管理在疫苗流通质量提升中的应用表现,并对其应用成效进行分析和评价.储配商评级管理体系涵盖9个方面、68项评分标准.本文通过对评级标准进行分析,以及对评级管理在疫苗流通质量提升方面的成效进行系统评价,旨在通过量化标准对储配商进行综合评价.储配商评级管理在疫苗流通质量提升中的应用,证明该制度能够有效促进储配商开展质量提升工作,从而为疫苗生产企业提供更安全、高效的仓储配送模式.

To improve the nationwide distribution efficiency of non-immunization program vaccines and reduce logistics costs,vaccine manufacturers have adopted a segmented relay distribution model consisting of"trunk transportation+regional warehousing+regional distribution"in compliance with relevant regulatory requirements for vaccine distribution.This model has facilitated the development of the vaccine distribution sector.At the same time,enterprises have established a rating management system for storage and distribution providers to promote continuous quality improvement in vaccine distribution.This paper systematically describes the application of provider rating management in enhancing vaccine distribution quality and evaluates its effectiveness.The rating management system comprises nine assessment dimensions and 68 scoring criteria.By analyzing the rating standards and systematically evaluating the outcomes of their implementation,this paper aims to provide a comprehensive and quantitative assessment framework for storage and distribution providers.The results demonstrate that the rating management system effectively promotes quality improvement activities among providers and supports the establishment of safer and more efficient warehousing and distribution models for vaccine manufacturers.

张伟;徐圆;喻莹;邓瑶函;王凌;聂希霖

武汉生物制品研究所有限责任公司武汉生物制品研究所有限责任公司武汉生物制品研究所有限责任公司武汉生物制品研究所有限责任公司武汉生物制品研究所有限责任公司武汉生物制品研究所有限责任公司

医药卫生

疫苗流通储配商评级管理质量提升成效评价

vaccine distributionstorage and distribution providersrating managementquality improvementeffectiveness evaluation

《中国食品药品监管》 2026 (6)

154-161,8

10.3969/j.issn.1673-5390.2026.06.015

评论